N.J. Admin. Code § 13:35-7.8

Current through Register Vol. 56, No. 24, December 18, 2024

Section 13:35-7.8 - Prohibitions and limitations in the prescribing, administering or dispensing of amphetamines and sympathomimetic amines

(a) A practitioner shall not prescribe, order, dispense, administer, sell or transfer any amphetamine or sympathomimetic amine designated as a Schedule II controlled substance for use in weight management, dieting or any other anorectic purpose, or for the treatment of fatigue.

(b) A practitioner may prescribe, dispense or administer amphetamine or sympathomimetic amine drugs or compounds designated as Schedule II controlled substances, only as follows:

1. For the treatment of the following conditions:

i. Narcolepsy established by recognized diagnostic criteria;

ii. Idiopathic Central Nervous System Hypersomnia established by recognized diagnostic criteria;

iii. Attention Deficit Disorder established by recognized diagnostic criteria;

iv. Drug-induced brain dysfunction;

v. Epilepsy;

vi. Depression shown to be refractory to other therapeutic modalities; and

vii. Senile apathetic behavior;

2. For immediate use in a hospital for acute conditions such as depression associated with illness or surgery;

3. For the differential diagnostic psychiatric evaluation of depression; or

4. For the clinical investigation of the effects of such drugs or compounds in which case, in addition to other requirements of applicable law, prior application therefor shall have been made to the Board and approval granted before any such investigation is begun.

(c) A practitioner who prescribes, dispenses or administers amphetamines or sympathomimetic amines shall prepare and maintain patient medical records which accurately reflect the utilization of any drug subject to this section, the specific diagnosis, the information upon which the diagnosis is based, including testing and consultations, and the treatment objectives for which the drug is being prescribed.

(d) The following list, although not exhaustive or exclusive, includes many of the generic and brand-name Schedule II drugs which are subject to this section:

Adderall

Amphetamine

Desoxyn

Dexedrine

Dextroamphetamine

Methamphetamine

Methylphenidate

Ritalin

N.J. Admin. Code § 13:35-7.8